New Biktarvy® Data Presented at IAS 2023 Further Demonstrate Safety and...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from multiple studies reinforcing Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg...
View ArticleGrindr Brings Free At-Home HIV Self-Test Kits to Europe for the First Time...
LOS ANGELES At the outset of European testing week, Grindr Inc. (NYSE: GRND), the world’s largest social network for the LGBTQ+ community, today announced the launch of its new partnerships with...
View ArticleUvax Bio Receives Approval to Initiate a Phase 1 Clinical Trial of Novel...
NEWARK, Del. Uvax Bio, LLC, a privately held, clinical-stage vaccine company, today announced acknowledgement from Australian Therapeutic Goods Administration and approval from the Human Research...
View ArticleUvax Bio Announces Dosing of First Participant in Phase 1 Clinical Trial...
NEWARK, Del. Uvax Bio, LLC, (“Uvax” or “the Company”) a privately held, clinical-stage vaccine company utilizing rational and computational biology to design and deliver novel 1c-SApNP®...
View ArticleYes! We Can End TB & AIDS, Says AHF
LOS ANGELES Join AIDS Healthcare Foundation (AHF) this World Tuberculosis (TB) Day, recognized annually on March 24, to raise awareness of one of the world’s deadliest infectious diseases, which is...
View ArticleGlobal SOS: Urgent Call to Revamp Pandemic Negotiations
LONDON AIDS Healthcare Foundation (AHF) will host a Zoom Press Conference WEDNESDAY, May 29 at 9:00 a.m. London time GMT+1 (4:00 a.m. US EDT) to comment on the stalled Pandemic Agreement...
View ArticleGilead and the Elton John AIDS Foundation Announce Additional Five Years of...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) and the Elton John AIDS Foundation (EJAF) today announced a five-year extension of the RADIAN® partnership to help meet the needs of the most...
View Article2 Million Lives in Care – AIDS Healthcare Foundation Reaches a Historic...
LOS ANGELES AIDS Healthcare Foundation (AHF) proudly announces a monumental achievement in its mission to provide cutting-edge medicine and advocacy regardless of ability to pay – 2 million lives in...
View ArticleGilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic...
FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical manufacturers to make...
View ArticleDr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to...
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”), today announced that it...
View Article